Literature DB >> 30048336

Integrating Public Health and Health Care Strategies to Address the Opioid Epidemic: The Oregon Health Authority's Opioid Initiative.

Katrina Hedberg1, Lisa T Bui, Catherine Livingston, Lisa M Shields, Joshua Van Otterloo.   

Abstract

CONTEXT: Oregon is experiencing an opioid overdose epidemic, similar to the United States as a whole. To address this crisis, the Oregon Health Authority (OHA) implemented a strategic Opioid Initiative, convening stakeholders and integrating public health and health care system activities across sectors. Recent data indicate progress: from 2015 to 2016, Oregon had the sharpest decline in prescription opioid overdose deaths of any state. PROGRAM: The Opioid Initiative, launched in 2015, focuses on integrating efforts to improve patient care and safety, and population health, by increasing access to nonopioid pain treatment, supporting medication-assisted treatment and naloxone access for people taking opioids, decreasing opioid prescribing, and using data to inform policies and interventions. IMPLEMENTATION: Four OHA projects highlight the integration: (1) a Medicaid Coordinated Care Organization Performance Improvement Project focused on decreasing risky opioid prescribing; (2) Health Evidence Review Commission guidelines that set coverage standards for opioid and nonopioid back pain treatments for Medicaid recipients; (3) statewide opioid prescribing guidelines; and (4) an opioid data dashboard. Each project involves a partnership between governmental public health, public and private health care systems, and external stakeholders. PROGRESS: From 2015 to 2017, the number of Oregonians on 90 or more Morphine Equivalent Doses (MEDs) decreased by 37%, from 11.1 per 1000 residents quarterly to 7.0 per 1000 residents quarterly. Prescription opioid overdose deaths decreased 20% from 4.5 per 100 000 in 2015 to 3.6 per 100 000 in 2016. Within the Medicaid population, the percentage of clients on 120 or more MEDs for 30 consecutive days decreased 27%, from 2.3% in December 2015 to 1.6% in September 2017. DISCUSSION: Oregon's integrated approach to address the opioid crisis spans public health and health care systems, engages key stakeholders, and uses data and evidence to inform policies. The progress to date is promising and may assist other states seeking to identify effective strategies to decrease opioid prescribing, misuse, and overdose.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30048336     DOI: 10.1097/PHH.0000000000000849

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  11 in total

1.  Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.

Authors:  Derjung M Tarn; Kevin J Shih; Allison J Ober; Sarah B Hunter; Katherine E Watkins; Jeremy Martinez; Alanna Montero; Michael McCreary; Isabel Leamon; John Sheehe; Elizabeth Bromley
Journal:  Community Ment Health J       Date:  2022-07-29

2.  Plan Type and Opioid Prescriptions for Children in Medicaid.

Authors:  Jordan Banks; Courtney Hill; Donald L Chi
Journal:  Med Care       Date:  2021-05-01       Impact factor: 3.178

Review 3.  Aligning healthcare, public health and social services: A scoping review of the role of purpose, governance, finance and data.

Authors:  Daniel Lanford; Aliza Petiwala; Glenn Landers; Karen Minyard
Journal:  Health Soc Care Community       Date:  2021-05-20

4.  Reducing Tobacco Use in Oregon Through Multisector Collaboration: Aligning Medicaid and Public Health Programs.

Authors:  Catherine J Livingston; Sarah E Bartelmann; Nancy M Goff; Kirsten G Aird
Journal:  Prev Chronic Dis       Date:  2020-12-10       Impact factor: 2.830

5.  Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions.

Authors:  Daniel M Hartung; Jonah Geddes; Sara E Hallvik; P Todd Korthuis; Luke Middleton; Gillian Leichtling; Christi Hildebran; Hyunjee Kim
Journal:  BMC Health Serv Res       Date:  2022-01-14       Impact factor: 2.655

6.  Use of Injection Drugs and Any Form of Methamphetamine in the Portland, OR Metro Area as a Driver of an HIV Time-Space Cluster: Clackamas, Multnomah, and Washington Counties, 2018-2020.

Authors:  Jaime Walters; Lea Busy; Christopher Hamel; Kelsi Junge; Timothy Menza; Jaxon Mitchell; Taylor Pinsent; Kim Toevs; Jennifer Vines
Journal:  AIDS Behav       Date:  2021-11-10

Review 7.  A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder.

Authors:  Alina Cernasev; Kenneth C Hohmeier; Kelsey Frederick; Hilary Jasmin; Justin Gatwood
Journal:  Explor Res Clin Soc Pharm       Date:  2021-06-04

8.  Experiences of Nonpharmacologic Providers Implementing the Oregon Back Pain Policy Expanding Services for Medicaid Recipients: A Focus Group Study.

Authors:  Mary Gray; Kate LaForge; Catherine J Livingston; Gillian Leichtling; Esther K Choo
Journal:  J Altern Complement Med       Date:  2021-07-14       Impact factor: 2.381

9.  Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy.

Authors:  Sara E Hallvik; Kirbee Johnston; Jonah Geddes; Gillian Leichtling; P Todd Korthuis; Daniel M Hartung
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-08-26       Impact factor: 2.732

10.  A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.

Authors:  Sanae El Ibrahimi; Sara Hallvik; Kirbee Johnston; Gillian Leichtling; Esther Choo; Daniel M Hartung
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-08-10       Impact factor: 2.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.